Why Celgene Corporation Stock Rocketed 13% Higher in October
Celgene was among the best biotech stocks in October after reporting favorable third-quarter earnings and clinical data. But, can the stock head even higher?
5 Things Celgene Corporation's Management Wants You to Know
Following another strong quarterly earnings report, here are five things Celgene's management team would like investors to know.